Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pharmacia Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 28/02/2012
SPC Depo-Medrone with Lidocaine

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
Date of revision of text on the SPC:   01-Feb-2012
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Name of MAH holder and PL number.
Updated on 11/11/2009 and displayed until 28/02/2012
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   01-Oct-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 4.8: There has been an amendment to the clinical data.
Updated on 17/04/2008 and displayed until 11/11/2009
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   01-Mar-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


4.4 – Addition of warning of potential psychiatric side-effects occurring with systemic steroids.

4.8 – Addition of psychiatric side-effects that have been reported with corticosteroids.
Updated on 11/09/2007 and displayed until 17/04/2008
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   05/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

7.1 – Change to the MAH address

10 – change in the date of revision
Updated on 24/08/2001 and displayed until 11/09/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Updated on 20/07/2001 and displayed until 24/08/2001
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 18/05/2001 and displayed until 20/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 12/09/2000 and displayed until 18/05/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 12/09/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  methylprednisolone
  lidocaine hydrochloride